| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $255K | -64.7% |
| Cost of Revenue | $72K | -59.0% |
| Gross Profit | $184K | -66.5% |
| R&D Expense | $1.8M | +45.9% |
| SG&A Expense | $5.7M | +15.2% |
| Operating Income | -$7.4M | -29.8% |
| Pre-tax Income | -$7.4M | -77.1% |
| Income Tax | $0 | -100.0% |
| Net Income | -$7.3M |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | -46.8% |
| Short-term Investments | $347K | -58.3% |
| Accounts Receivable | $202K | -41.1% |
| Inventory | $38K | +29.6% |
| Current Assets | $7.0M | -43.9% |
| Total Assets | $7.8M | -41.0% |
| Current Liabilities | $194K | +26.6% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | -22.3% |
| Investing Cash Flow | -$181K | -193.2% |
| Financing Cash Flow | -$45K | -100.3% |
| -73.7% |
| Total Liabilities |
| $201K |
| -0.9% |
| Stockholders' Equity | $7.9M | -39.2% |